CD8A and neoplasm: These changes in the tumor microenvironment collectively support cross-priming of tumor-directed CD8+ T cells and simultaneously increase the vulnerability of tumor cells to the immune system, thus ultimately inducing both local and systemic immune-mediated tumor cell killing6,7.